The ALS: Opioid Module is designed to help clinical team members provide immediate treatment and care for adult opioid overdose victims. Course content includes the following:
• Pathophysiology of opioid overdose
• Special considerations on how to care for overdose patients, including naloxone administration
• Recognizing the need for high-quality CPR and the use of a defibrillator as indicated
• Information on the importance and types of resources available for individuals after an opioid overdose, including medication-assisted therapies
After successfully completing this course, students should be able to:
• Describe the current opioid epidemic in the U.S.
• Explain the pathophysiology of chronic opioid use
• Describe the pathophysiology of opioid overdose
• Describe the efficacy of naloxone for opioid overdose
• Review care considerations for comprehensive treatment after an opioid overdose
This eLearning course features True Adaptive™ learning, where students follow a learning path personalized by their own inputs and self-reported confidence level.
Bundle & Save! Save up to 10% when you purchase ALS modules as a bundle.
Learn More >
Please refer to elearning.heart.org for specific course technical requirements.
Especificaciones del producto
- Associated Course : ALS
- Format : Online Course
- Product Type : Blended and eLearning
• Features engaging, True Adaptive™ learning
• Responsive design ensures compatibility on mobile devices and tablets
• Students can select their level of competence as they begin the course and can change their selection at any time during the course
• All curriculum is web-accessible through inclusive design (WCAG 2.1 AA)
• Ease of use for more students - works on all common browsers (no more Flash)
Información sobre capacitación continua
- Possible CE 0.25
Joint Accreditation: 10/19/2022 – 10/18/2025
CAPCE: 10/19/2022 – 10/18/2025
Joint Accreditation Statements
In support of improving patient care, this activity has been planned and implemented by The American Heart Association. The American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AMA Credit Designation Statement - Physicians
The American Heart Association designates this activity for a maximum of 0.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA Credit Acceptance Statement – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 0.25 hours of Category I credit for completing this program.
AANP Credit Acceptance Statement – Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.
Continuing Education Accreditation – Emergency Medical Services
This continuing education activity is approved by the American Heart Association, an organization accredited by the Commission on Accreditation of Pre-Hospital Continuing Education (CAPCE), for 0.25 Advanced CEHs, activity number 22-AMHA-F3-0041.
By claiming CAPCE credit, the claimant acknowledges the following: I understand that the American Heart Association as a requirement of CAPCE accreditation will submit a record of my course completions to the CAPCE AMS. I further understand that my course completion records may be accessed by or shared with such regulators as state EMS offices, training officers, and NREMT on a password-protected, need-to-know basis. In addition, I understand that I may review my record of CAPCE-accredited course completions by contacting CAPCE.
All persons in a position to control educational content of a CE activity provided by the American Heart Association must disclose to the audience all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. The presence or absence of all financial relationships will be disclosed to the audience in activity materials. All unlabeled/unapproved uses of drugs or devices discussed will also be disclosed to the audience. All relevant financial relationships have been mitigated prior to the commencement of the activity.
This self-directed module is designed for advanced healthcare providers who are seeking additional content beyond ACLS and Continuing Education (CE) credit.
The intended audiences for ALS: Opioid are Paramedics, ED Physicians, NPs/APNs, ED Nurses, Advanced EMTs, Hospitalists, and PAs.